Primary |
Atrial Flutter |
50.0% |
Atrial Fibrillation |
33.3% |
Coronary Artery Stenosis |
16.7% |
|
Gastrointestinal Hypomotility |
40.0% |
Foetal Growth Restriction |
20.0% |
Gait Disturbance |
20.0% |
Ileus Paralytic |
20.0% |
|
Secondary |
Hypertension |
50.0% |
Breast Cancer |
41.7% |
Atrial Fibrillation |
8.3% |
|
Neuropathy Peripheral |
30.0% |
Peripheral Sensory Neuropathy |
20.0% |
Cardio-respiratory Arrest |
10.0% |
Condition Aggravated |
10.0% |
Death |
10.0% |
Drug Hypersensitivity |
10.0% |
Therapeutic Response Unexpected With Drug Substitution |
10.0% |
|
Concomitant |
Product Used For Unknown Indication |
33.9% |
Drug Use For Unknown Indication |
31.6% |
Hypertension |
7.6% |
Osteoporosis |
4.2% |
Hormone Replacement Therapy |
3.6% |
Thrombosis Prophylaxis |
2.3% |
Diabetes Mellitus |
1.9% |
Asthma |
1.5% |
Chronic Obstructive Pulmonary Disease |
1.5% |
Anaemia |
1.3% |
Colonoscopy |
1.3% |
Fibromyalgia |
1.3% |
Pain |
1.3% |
Angiogram |
1.1% |
Blood Cholesterol Increased |
1.1% |
Coronary Artery Bypass |
1.1% |
Dyslipidaemia |
1.1% |
Migraine |
1.1% |
Arthritis |
0.8% |
Blood Pressure |
0.8% |
|
Swelling |
8.5% |
Tooth Abscess |
8.5% |
Visual Impairment |
8.5% |
Breast Cancer |
6.8% |
Psychomotor Hyperactivity |
6.8% |
Vision Blurred |
6.8% |
Death |
5.1% |
Diarrhoea |
5.1% |
Ulcer |
5.1% |
Weight Decreased |
5.1% |
Acute Myocardial Infarction |
3.4% |
Depression |
3.4% |
Dysphonia |
3.4% |
Hypersensitivity |
3.4% |
Loss Of Consciousness |
3.4% |
Malaise |
3.4% |
Muscle Spasms |
3.4% |
Musculoskeletal Disorder |
3.4% |
Renal Failure |
3.4% |
Renal Failure Acute |
3.4% |
|
Interacting |
Heart Rate Irregular |
100.0% |
|
|